1. Home
  2. DOMO vs ABEO Comparison

DOMO vs ABEO Comparison

Compare DOMO & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$8.91

Market Cap

477.0M

Sector

Technology

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.46

Market Cap

281.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMO
ABEO
Founded
2010
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
477.0M
281.0M
IPO Year
2018
1980

Fundamental Metrics

Financial Performance
Metric
DOMO
ABEO
Price
$8.91
$5.46
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$15.22
$18.20
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
12-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.29
Revenue
$318,002,000.00
$400,000.00
Revenue This Year
$2.28
N/A
Revenue Next Year
$2.45
$1,589.77
P/E Ratio
N/A
$4.24
Revenue Growth
N/A
N/A
52 Week Low
$6.01
$3.93
52 Week High
$18.49
$7.54

Technical Indicators

Market Signals
Indicator
DOMO
ABEO
Relative Strength Index (RSI) 36.01 59.14
Support Level $8.63 $4.80
Resistance Level $9.22 $5.55
Average True Range (ATR) 0.43 0.26
MACD 0.11 0.04
Stochastic Oscillator 51.52 80.75

Price Performance

Historical Comparison
DOMO
ABEO

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: